The use of Interferon-γ release assays for Tuberculosis Screening in International TravelersArchived
IGRAs are increasingly being considered for the diagnosis of LTBI, as a replacement to the TST, including travel medicine. As with the TST, many uncertainties remain with regard to the efficacy of the IGRAs. It is therefore essential to secure an accurate understanding of these assays‘ known efficacy, so that they be optimally used and only in context with proven effect.
Factors associated with Legionnaires' disease recurrence in hotel and holiday rental accommodation sites
Beauté, J., Sandin, S., de Jong, B., Hallström, L.P., Robesyn, E., Giesecke, J., Sparén, P., On Behalf Of The European Legionnaires' Disease Surveillance Network